Bio-Rad QX200 Droplet Digital PCR (ddPCR) System

Closed Pre-Solicitation Posted

Solicitation number
75N98026Q01194
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health intends to award a firm-fixed-price purchase order for a Bio-Rad QX200 Droplet Digital PCR (ddPCR) System on a sole-source basis to Bio-Rad Laboratories, Inc., with capability statements due by 9:00 a.m. EDT on September 17, 2026. The procurement is being conducted under FAR 6.302-1 (only one responsible source); Bio-Rad Laboratories is the sole manufacturer of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology, which employs microfluidic droplet partitioning for absolute quantification of nucleic acid targets with high precision and sensitivity. No alternative commercially available system provides the specific combination of capabilities required.

This is not a competitive solicitation; however, any responsible source, including 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business concerns, may submit a capability statement demonstrating ability to provide an equivalent system meeting the Government's minimum technical requirements. Capability statements must include sufficient documentation establishing the ability to furnish an equivalent product. The Government reserves discretion to determine whether to compete the acquisition based on responses received. Award is anticipated approximately five days after the September 17 closing date. Responses must be submitted via email to vensonm@mail.nih.gov.

Notice text

Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.

                                                       (75N98026Q01194)

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

The National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.

Bio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity.

No alternative commercially available system provides the specific combination of capabilities.

This notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.

A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.

Responses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside
NOI - 4D-Nucleofector Core Unit and X Unit NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
NCSS - Bioruptor Pico Sonication Device NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use) Bethesda, Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors